Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1963 1
1964 1
1965 2
1968 1
1969 1
1971 1
1972 1
1988 2
1990 1
1991 1
1992 1
1993 1
2018 1
2019 7
2020 2
2021 9
2022 4
2023 3
2025 2
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort.
Winsko-Szczęsnowicz K, Pieniążek M, Polakiewicz-Gilowska A, Kubeczko M, Holánek M, Malejčíková M, Soumarová R, Študentová H, Konieczna A, Młodzińska A, Żubrowska J, Lisik-Habib M, Pękala A, Krejčí D, Šustr J, Kolářová I, Danielewicz I, Szymanik-Resko M, Ciszewski T, Rusinová L, Czartoryska-Arłukowicz B, Łacko A, Jarząb M, Bielčiková Z, Pacholczak-Madej R, Püsküllüoğlu M. Winsko-Szczęsnowicz K, et al. Among authors: krejci d. Clin Transl Oncol. 2026 Feb 2. doi: 10.1007/s12094-026-04236-5. Online ahead of print. Clin Transl Oncol. 2026. PMID: 41627638
Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe.
Pieniążek M, Polakiewicz-Gilowska A, Żubrowska J, Rušinová L, Študentová H, Konieczna A, Młodzińska A, Winsko-Szczęsnowicz K, Lisik-Habib M, Pękala A, Krejčí D, Šustr J, Kolářová I, Danielewicz I, Szymanik-Resko M, Soumarová R, Ciszewski T, Holánek M, Czartoryska-Arłukowicz B, Łacko A, Smok-Kalwat J, Jarząb M, Pacholczak-Madej R, Malejčíková M, Bielčiková Z, Püsküllüoğlu M. Pieniążek M, et al. Among authors: krejci d. Oncologist. 2026 Feb 5;31(3):oyag014. doi: 10.1093/oncolo/oyag014. Oncologist. 2026. PMID: 41578063 Free article.
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study.
Żubrowska J, Pieniążek M, Polakiewicz-Gilowska A, Rušinová L, Soumarová R, Študentová H, Konieczna A, Młodzińska A, Winsko-Szczęsnowicz K, Lisik-Habib M, Pękala A, Krejčí D, Šustr J, Kolářová I, Danielewicz I, Szymanik-Resko M, Ciszewski T, Holánek M, Czartoryska-Arłukowicz B, Łacko A, Smok-Kalwat J, Jarząb M, Pacholczak-Madej R, Ługowska I, Bielčiková Z, Malejčíková M, Püsküllüoğlu M. Żubrowska J, et al. Among authors: krejci d. Breast. 2026 Feb;85:104699. doi: 10.1016/j.breast.2026.104699. Epub 2026 Jan 12. Breast. 2026. PMID: 41564659 Free PMC article.
Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.
Żubrowska J, Pieniążek M, Polakiewicz-Gilowska A, Kolářová I, Malejčíková M, Rušinová L, Holánek M, Soumarová R, Winsko-Szczęsnowicz K, Konieczna A, Młodzińska A, Krejčí D, Danielewicz I, Szymanik-Resko M, Ciszewski T, Lisik-Habib M, Pękala A, Študentová H, Šustr J, Rudzińska A, Kubeczko M, Czartoryska-Arłukowicz B, Smok-Kalwat J, Łacko A, Jarząb M, Pacholczak-Madej R, Bielčiková Z, Püsküllüoğlu M. Żubrowska J, et al. Among authors: krejci d. J Neurooncol. 2026 Jan 14;176(2):167. doi: 10.1007/s11060-025-05394-2. J Neurooncol. 2026. PMID: 41533274 No abstract available.
Secondary malignancies and survival of FCR-treated patients with chronic lymphocytic leukemia in Central Europe.
Kósa F, Nečasová T, Špaček M, Giannopoulos K, Hus I, Jurková T, Koriťáková E, Chrápavá M, Nováčková M, Katinová I, Krejčí D, Jujka A, Mátrai Z, Vályi-Nagy I, Robak T, Doubek M. Kósa F, et al. Among authors: krejci d. Cancer Med. 2023 Jan;12(2):1961-1971. doi: 10.1002/cam4.5033. Epub 2022 Oct 7. Cancer Med. 2023. PMID: 36205198 Free PMC article.
47 results